Lanean...
COVID-19 antibodies on trial
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
Gorde:
| Argitaratua izan da: | Nat Biotechnol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group US
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576980/ https://ncbi.nlm.nih.gov/pubmed/33087898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41587-020-0732-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|